Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma and the SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids in adult patients with evaporative dry eye disease due to meibomian gland disfunction.
Código da empresaSGHT
Nome da EmpresaSight Sciences Inc
Data de listagemJul 15, 2021
CEOMr. Paul Badawi
Número de funcionários216
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 15
Endereço4040 Campbell Ave,
CidadeMENLO PARK
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94025
Telefone14158890550
Sitehttps://www.sightsciences.com/
Código da empresaSGHT
Data de listagemJul 15, 2021
CEOMr. Paul Badawi
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados